SHANGHAI – Sciclone Pharmaceuticals Inc., of Foster City, Calif., will pay $12.8 million to settle charges that it violated the Foreign Corrupt Practices Act (FCPA) when its international subsidiaries reportedly increased sales by making improper payments to health care professionals employed at state health institutions in China.